| 1 |
Cui Y, Li M, Hong X, Du D, Ma Y. Solid-phase interfacial synthesis of dual-imprinted colloid particles for multifunctional nanomedicine development. Colloid and Interface Science Communications 2020;36:100267. [DOI: 10.1016/j.colcom.2020.100267] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 2 |
Padilla-Godínez FJ, Ramos-Acevedo R, Martínez-Becerril HA, Bernal-Conde LD, Garrido-Figueroa JF, Hiriart M, Hernández-López A, Argüero-Sánchez R, Callea F, Guerra-Crespo M. Protein Misfolding and Aggregation: The Relatedness between Parkinson's Disease and Hepatic Endoplasmic Reticulum Storage Disorders. Int J Mol Sci 2021;22:12467. [PMID: 34830348 DOI: 10.3390/ijms222212467] [Reference Citation Analysis]
|
| 3 |
Zhu X, Zhang B, He Y, Bao J. Liver Organoids: Formation Strategies and Biomedical Applications. Tissue Eng Regen Med 2021;18:573-85. [PMID: 34132985 DOI: 10.1007/s13770-021-00357-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 4 |
Nuciforo S, Heim MH. Organoids to model liver disease. JHEP Rep 2021;3:100198. [PMID: 33241206 DOI: 10.1016/j.jhepr.2020.100198] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
|
| 5 |
Fromme M, Schneider CV, Trautwein C, Brunetti-Pierri N, Strnad P. Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder. J Hepatol 2021:S0168-8278(21)02227-3. [PMID: 34848258 DOI: 10.1016/j.jhep.2021.11.022] [Reference Citation Analysis]
|
| 6 |
Brooks A, Liang X, Zhang Y, Zhao CX, Roberts MS, Wang H, Zhang L, Crawford DHG. Liver organoid as a 3D in vitro model for drug validation and toxicity assessment. Pharmacol Res 2021;169:105608. [PMID: 33852961 DOI: 10.1016/j.phrs.2021.105608] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 7 |
Funata M, Nio Y, Erion DM, Thompson WL, Takebe T. The promise of human organoids in the digestive system. Cell Death Differ 2021;28:84-94. [PMID: 33204011 DOI: 10.1038/s41418-020-00661-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Lehmann V, Schene IF, Ardisasmita AI, Liv N, Veenendaal T, Klumperman J, van der Doef HPJ, Verkade HJ, Verstegen MMA, van der Laan LJW, Jans JJM, Verhoeven-Duif NM, van Hasselt PM, Nieuwenhuis EES, Spee B, Fuchs SA. The potential and limitations of intrahepatic cholangiocyte organoids to study inborn errors of metabolism. J Inherit Metab Dis 2021. [PMID: 34671987 DOI: 10.1002/jimd.12450] [Reference Citation Analysis]
|
| 9 |
Yu JH, Ma S. Organoids as research models for hepatocellular carcinoma. Exp Cell Res 2021;411:112987. [PMID: 34942189 DOI: 10.1016/j.yexcr.2021.112987] [Reference Citation Analysis]
|
| 10 |
Sassi L, Ajayi O, Campinoti S, Natarajan D, McQuitty C, Siena RR, Mantero S, De Coppi P, Pellegata AF, Chokshi S, Urbani L. A Perfusion Bioreactor for Longitudinal Monitoring of Bioengineered Liver Constructs. Nanomaterials (Basel) 2021;11:275. [PMID: 33494337 DOI: 10.3390/nano11020275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Bhattacharyya C, Das C, Ghosh A, Singh AK, Mukherjee S, Majumder PP, Basu A, Biswas NK. SARS-CoV-2 mutation 614G creates an elastase cleavage site enhancing its spread in high AAT-deficient regions. Infect Genet Evol 2021;90:104760. [PMID: 33556558 DOI: 10.1016/j.meegid.2021.104760] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
|
| 12 |
Xie Y, Yao J, Jin W, Ren L, Li X. Induction and Maturation of Hepatocyte-Like Cells In Vitro: Focus on Technological Advances and Challenges. Front Cell Dev Biol 2021;9:765980. [PMID: 34901010 DOI: 10.3389/fcell.2021.765980] [Reference Citation Analysis]
|
| 13 |
Kunst RF, Niemeijer M, van der Laan LJW, Spee B, van de Graaf SFJ. From fatty hepatocytes to impaired bile flow: Matching model systems for liver biology and disease. Biochem Pharmacol 2020;180:114173. [PMID: 32717228 DOI: 10.1016/j.bcp.2020.114173] [Reference Citation Analysis]
|
| 14 |
Luce E, Messina A, Duclos-Vallée JC, Dubart-Kupperschmitt A. Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. Hepatology 2021;74:1101-16. [PMID: 33420753 DOI: 10.1002/hep.31705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 15 |
Lam DTUH, Dan YY, Chan YS, Ng HH. Emerging liver organoid platforms and technologies. Cell Regen 2021;10:27. [PMID: 34341842 DOI: 10.1186/s13619-021-00089-1] [Reference Citation Analysis]
|
| 16 |
Kamies R, Martinez-Jimenez CP. Advances of single-cell genomics and epigenomics in human disease: where are we now? Mamm Genome 2020;31:170-80. [PMID: 32270277 DOI: 10.1007/s00335-020-09834-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 17 |
Nikokiraki C, Psaraki A, Roubelakis MG. The Potential Clinical Use of Stem/Progenitor Cells and Organoids in Liver Diseases. Cells 2022;11:1410. [DOI: 10.3390/cells11091410] [Reference Citation Analysis]
|
| 18 |
Xu Q. Human Three-Dimensional Hepatic Models: Cell Type Variety and Corresponding Applications. Front Bioeng Biotechnol 2021;9:730008. [PMID: 34631680 DOI: 10.3389/fbioe.2021.730008] [Reference Citation Analysis]
|
